GGrantIndex
Sort

24,576 grants matching microbiome

University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)

$2,736,516
Ann R Falsey · University Of Rochester · UM1 · FY2022 · AI

Aging Intervention Studies

$2,736,062
Julie Mattison · National Institute On Aging · ZIA · FY2023 · AG

The UNC Chapel Hill Superfund Research Program (UNC-SRP)

$2,733,717
Rebecca Fry · Univ Of North Carolina Chapel Hill · P42 · FY2020 · ES

Investigations of Methylmalonic Acidemia and Related Disorders

$2,733,586
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2024 · HG

Eukaryotic Transcriptional Regulation

$2,719,920
Paul A Wade · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES

Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina

$2,717,200
Rachel R. Caspi · National Eye Institute · ZIA · FY2017 · EY

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,714,385
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2018 · HL

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,713,336
Alison Morris · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · HL

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,713,014
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · HL

University of Washington Sexually Transmitted Infections Cooperative Research Cen

$2,710,804
Anna Wald · University Of Washington · U19 · FY2017 · AI

Molecular Genomics Sequencing Core Facility

$2,705,152
Steven Coon · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIC · FY2020 · HD

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,704,375
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · HL

Molecular Genetic Approaches in Atherosclerosis Research

$2,704,188
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2016 · HL

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,700,395
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · HL

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)

$2,696,667
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2025 · DA

Molecular Genetic Approaches in Atherosclerosis Research

$2,693,389
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2019 · HL

Molecular Genetic Approaches in Atherosclerosis Research

$2,693,389
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2018 · HL

Human Trisome Project - Latin America Network

$2,693,143
Joaquin M. Espinosa · University Of Colorado Denver · U01 · FY2024 · HD

Molecular Genetic Approaches in Atherosclerosis Research

$2,691,229
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2017 · HL

Development of rationally designed HIV vaccines

$2,689,105
Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Ca2+ signaling and HCO3- secretion by exocrine glands

$2,685,632
Shmuel Muallem · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE

Early Life Adversity, Biological Embedding, and Risk for Developmental Precursors of Mental Disorders

$2,684,011
Joan L Luby · Washington University · R01 · FY2025 · MH

The 10,000 Families Cohort: a new study to understand the environmental causes of cancer

$2,680,175
Jenny N. Poynter · University Of Minnesota · UH3 · FY2023 · CA

Investigations of Methylmalonic Acidemia and Related Disorders

$2,679,986
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2023 · HG

The multifaceted role of acetate in cancer

$2,679,000
Zachary T Schug · Wistar Institute · DP2 · FY2019 · CA